BDNF and neoplasm: Neurotransmitters, neurotrophins and axon−guidance molecules modulate myeloid polarisation and T−cell activity, while inflammatory mediators reciprocally influence neuritogenesis and neural plasticity, collectively favouring tumour persistence along neural routes (31, 32).